Immune markers, diurnal blood pressure profile and cardiac function in virologically suppressed HIV-infected patients

Blood Press. 2017 Dec;26(6):332-340. doi: 10.1080/08037051.2017.1346459. Epub 2017 Jul 4.

Abstract

Purpose: Non-dipping nocturnal blood pressure (BP) pattern has been reported prevalent among HIV-infected patients and is associated with adverse cardiovascular outcomes. The aims of this observational study were to identify predictors of nocturnal BP decline, and to explore whether diurnal BP profile is associated with alterations in cardiac structure and function.

Materials and methods: A total of 108 treated HIV-infected patients with suppressed viremia underwent ambulatory BP measurement, 51 of these patients also underwent echocardiography.

Results: Non-dipping nocturnal BP pattern was present in 51% of the patients. Decreased nocturnal decline in systolic BP (SBP) correlated with lower CD4 count (rsp = 0.21, p = 0.032) and lower CD4/CD8 ratio (rsp = 0.26, p = 0.008). In multivariate linear regression analyses, lower BMI (p = 0.015) and CD4/CD8 ratio <0.4 (p = 0.010) remained independent predictors of nocturnal decline in SBP. Nocturnal decline in SBP correlated with impaired diastolic function, e' (r = 0.28, p = 0.049) as did nadir CD4 count (rsp = 0.38, p = 0.006). In multivariate linear regression analyses, nadir CD4 count <100 cells/μL (p = 0.037) and age (p < 0.001) remained independent predictors of e'.

Conclusions: Compromised immune status may contribute to attenuated diurnal BP profile as well as impaired diastolic function in well-treated HIV infection.

Keywords: CD4/CD8 ratio; HIV infection; diastolic dysfunction; echocardiography; nadir CD4 lymphocyte count; non-dipping blood pressure pattern.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Biomarkers / analysis
  • Blood Pressure Monitoring, Ambulatory
  • Blood Pressure*
  • CD4-CD8 Ratio
  • Circadian Rhythm
  • Diastole
  • Female
  • HIV Infections / complications
  • HIV Infections / physiopathology*
  • Heart / physiopathology*
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged

Substances

  • Biomarkers